173 related articles for article (PubMed ID: 36644859)
1. Vaccination effects on post-infection outcomes in the Omicron BA.2 outbreak in Shanghai.
Wu Q; Wang H; Cai J; Ai J; Li Y; Zhang H; Wang S; Sun F; Wu Y; Zhou J; Wang Y; Yu H; Zhang W
Emerg Microbes Infect; 2023 Dec; 12(1):e2169197. PubMed ID: 36644859
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of COVID-19 vaccines against SARS-CoV-2 Omicron variants during two outbreaks from March to May 2022 in Quzhou, China.
Yin Z; Fang Q; Wen T; Zheng C; Fu C; Wang S; Li J; Gong X
Hum Vaccin Immunother; 2023 Dec; 19(1):2163813. PubMed ID: 36704960
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of booster vaccination with inactivated COVID-19 vaccines against SARS-CoV-2 Omicron BA.2 infection in Guangdong, China: a cohort study.
He X; Zeng B; Wang Y; Pang Y; Zhang M; Hu T; Liang Y; Kang M; Tang S
Front Immunol; 2023; 14():1257360. PubMed ID: 37915583
[TBL] [Abstract][Full Text] [Related]
4. Estimation of disease burden and clinical severity of COVID-19 caused by Omicron BA.2 in Shanghai, February-June 2022.
Chen X; Yan X; Sun K; Zheng N; Sun R; Zhou J; Deng X; Zhuang T; Cai J; Zhang J; Ajelli M; Yu H
medRxiv; 2022 Jul; ():. PubMed ID: 35898339
[TBL] [Abstract][Full Text] [Related]
5. Host protection against Omicron BA.2.2 sublineages by prior vaccination in spring 2022 COVID-19 outbreak in Shanghai.
Fu Z; Liang D; Zhang W; Shi D; Ma Y; Wei D; Xi J; Yang S; Xu X; Tian D; Zhu Z; Guo M; Jiang L; Yu S; Wang S; Jiang F; Ling Y; Wang S; Chen S; Liu F; Tan Y; Fan X
Front Med; 2023 Jun; 17(3):562-575. PubMed ID: 36949347
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of inactivated and Ad5-nCoV COVID-19 vaccines against SARS-CoV-2 Omicron BA. 2 variant infection, severe illness, and death.
Huang Z; Xu S; Liu J; Wu L; Qiu J; Wang N; Ren J; Li Z; Guo X; Tao F; Chen J; Lu D; Sun X; Wang W
BMC Med; 2022 Oct; 20(1):400. PubMed ID: 36266697
[TBL] [Abstract][Full Text] [Related]
7. Transmission Characteristics and Inactivated Vaccine Effectiveness Against Transmission of SARS-CoV-2 Omicron BA.5 Variants in Urumqi, China.
Wang K; Guo Z; Zeng T; Sun S; Lu Y; Wang J; Li S; Luan Z; Li H; Zhang J; Wang Y; Lu Y; Zhao S
JAMA Netw Open; 2023 Mar; 6(3):e235755. PubMed ID: 36995713
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological and clinical features of SARS-CoV-2 infection in children during the outbreak of Omicron variant in Shanghai, March 7-31, 2022.
Wang X; Chang H; Tian H; Zhu Y; Li J; Wei Z; Wang Y; Xia A; Ge Y; Liu G; Cai J; Zhu Q; Zhai X; Zeng M
Influenza Other Respir Viruses; 2022 Nov; 16(6):1059-1065. PubMed ID: 36043446
[TBL] [Abstract][Full Text] [Related]
9. Inactivated vaccine effectiveness against symptomatic COVID-19 in Fujian, China during the Omicron BA.2 outbreak.
Ye W; Li K; Zhao Z; Wu S; Qu H; Guo Y; Abudunaibi B; Chen W; Cai S; Chen C; Lin J; Xie Z; Zhan M; Ou J; Deng Y; Chen T; Zheng K
Front Public Health; 2023; 11():1269194. PubMed ID: 38162626
[TBL] [Abstract][Full Text] [Related]
10. Vaccination status for mild and asymptomatic infections with SARS-CoV-2 Omicron BA.2 variant in Shanghai.
Yin Y; Lin J; Yuan S; Tong S; He Y; Dong B; Zhang F; Chen E; Zheng J; Wang W
J Med Virol; 2023 May; 95(5):e28767. PubMed ID: 37212341
[TBL] [Abstract][Full Text] [Related]
11. Impact of inactivated vaccines on decrease of viral RNA levels in individuals with the SARS-CoV-2 Omicron (BA.2) variant: A retrospective cohort study in Shanghai, China.
Yang P; Dang B; Kang W; Li X; Wang T; Li R; Peng M; Liu Y; Wang L; Cheng Y; Yu S; Wei M; Gao H; Kang W; Shang L
Front Public Health; 2023; 11():1107343. PubMed ID: 36960364
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022.
Britton A; Embi PJ; Levy ME; Gaglani M; DeSilva MB; Dixon BE; Dascomb K; Patel P; Schrader KE; Klein NP; Ong TC; Natarajan K; Hartmann E; Kharbanda AB; Irving SA; Dickerson M; Dunne MM; Raiyani C; Grannis SJ; Stenehjem E; Zerbo O; Rao S; Han J; Sloan-Aagard C; Griggs EP; Weber ZA; Murthy K; Fadel WF; Grisel N; McEvoy C; Lewis N; Barron MA; Nanez J; Reese SE; Mamawala M; Valvi NR; Arndorfer J; Goddard K; Yang DH; Fireman B; Ball SW; Link-Gelles R; Naleway AL; Tenforde MW
MMWR Morb Mortal Wkly Rep; 2022 Oct; 71(42):1335-1342. PubMed ID: 36264840
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive analysis of the efficacy and effectiveness of COVID-19 vaccines.
He X; Su J; Ma Y; Zhang W; Tang S
Front Immunol; 2022; 13():945930. PubMed ID: 36090988
[TBL] [Abstract][Full Text] [Related]
14. Facing the Omicron variant-how well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review.
Külper-Schiek W; Piechotta V; Pilic A; Batke M; Dreveton LS; Geurts B; Koch J; Köppe S; Treskova M; Vygen-Bonnet S; Waize M; Wichmann O; Harder T
Front Immunol; 2022; 13():940562. PubMed ID: 36091023
[TBL] [Abstract][Full Text] [Related]
15. Circulating eosinophils associated with responsiveness to COVID-19 vaccine and the disease severity in patients with SARS-CoV-2 omicron variant infection.
Zhu Z; Cai J; Tang Q; Mo YY; Deng T; Zhang X; Xu K; Wu B; Tang H; Zhang Z
BMC Pulm Med; 2023 May; 23(1):177. PubMed ID: 37217986
[TBL] [Abstract][Full Text] [Related]
16. Estimated BNT162b2 Vaccine Effectiveness Against Infection With Delta and Omicron Variants Among US Children 5 to 11 Years of Age.
Khan FL; Nguyen JL; Singh TG; Puzniak LA; Wiemken TL; Schrecker JP; Taitel MS; Zamparo JM; Jodar L; McLaughlin JM
JAMA Netw Open; 2022 Dec; 5(12):e2246915. PubMed ID: 36515946
[TBL] [Abstract][Full Text] [Related]
17. Estimation of disease burden and clinical severity of COVID-19 caused by Omicron BA.2 in Shanghai, February-June 2022.
Chen X; Yan X; Sun K; Zheng N; Sun R; Zhou J; Deng X; Zhuang T; Cai J; Zhang J; Ajelli M; Yu H
Emerg Microbes Infect; 2022 Dec; 11(1):2800-2807. PubMed ID: 36205530
[TBL] [Abstract][Full Text] [Related]
18. Vaccine effectiveness against Delta, Omicron BA.1, and BA.2 in a highly vaccinated Asian setting: a test-negative design study.
Tan CY; Chiew CJ; Pang D; Lee VJ; Ong B; Lye DC; Tan KB
Clin Microbiol Infect; 2023 Jan; 29(1):101-106. PubMed ID: 36028091
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: a descriptive study.
Chen Z; Deng X; Fang L; Sun K; Wu Y; Che T; Zou J; Cai J; Liu H; Wang Y; Wang T; Tian Y; Zheng N; Yan X; Sun R; Xu X; Zhou X; Ge S; Liang Y; Yi L; Yang J; Zhang J; Ajelli M; Yu H
medRxiv; 2022 Jun; ():. PubMed ID: 35765564
[TBL] [Abstract][Full Text] [Related]
20. Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.
Ng OT; Marimuthu K; Lim N; Lim ZQ; Thevasagayam NM; Koh V; Chiew CJ; Ma S; Koh M; Low PY; Tan SB; Ho J; Maurer-Stroh S; Lee VJM; Leo YS; Tan KB; Cook AR; Tan CC
JAMA Netw Open; 2022 Aug; 5(8):e2228900. PubMed ID: 36018588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
